Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518213
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518214
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518217
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518220
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518151
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518233
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518234
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518230
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518227
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518240
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518242
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518235
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518238
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518247
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518249
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518250
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518252
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518254
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518255
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518258
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518244
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518261
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518263
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518265
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518245
Officers of the Russian Federal Penitentiary Service's special forces take part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8518267
An officer of the Russian Federal Penitentiary Service's special forces takes part in qualification tests to earn the maroon beret in Saransk, Republic of Mordovia, Russia.15.09.2023#8517978
A view shows the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401343
An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401386
An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401387
A view shows the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401389
A view shows the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401391
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401357
A view shows thermostats at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401363
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401370
Employees work at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401396
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401378
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401381
An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401384
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401437
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401439
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401448
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401453
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401452
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401451
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401444
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401420
A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401421
A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401424
A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401431
An employee adjusts an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401434
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401454
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401497
Tablets are seen in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401498
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401468
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401457
A tablet breaking force tester is seen in a workshop No.9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401486
A view shows scales for tablets weighing in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401490
A view shows scales for tablets weighing in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401492
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401493
